A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies (CaDAnCe-101)
NCT 05006716 Brief Summary Study consists of two main parts to explore…
Read more arrow_forwardNCT 05006716 Brief Summary Study consists of two main parts to explore…
Read more arrow_forwardNCT 05999994 Brief Summary The main purpose of the master is to…
Read more arrow_forwardNCT 06528301 Brief Summary This study is a Phase 1 dose-escalation and…
Read more arrow_forwardACTRN 12622000308796 Brief Summary The purpose of this study is to investigate…
Read more arrow_forwardACTRN 12622000993796 Brief Summary AXA-042 functions through a multi-cellular mechanism to re-engage…
Read more arrow_forwardACTRN 12622001339741 Brief Summary This is a first in human study of…
Read more arrow_forwardNCT 04923048 Brief Summary This is a Phase 1/2 study of GB261…
Read more arrow_forwardNCT 04923048 Brief Summary This is a Phase 1/2 study of GB261…
Read more arrow_forwardACTRN 12621000507886 Brief Summary This is a substudy of the Cancer Molecular…
Read more arrow_forwardNCT 06929663 Brief Summary This is an first-in-human, Phase I clinical study…
Read more arrow_forward